Millennium Medical Publishing, Inc

SHERPA: Unknown

People

  1. Horwitz
    Horwitz
  2. Slovin
    Slovin
  3. Zelenetz
    Zelenetz
  4. Berman
    Berman
  5. Falchi
    Falchi
  6. Giralt
    Giralt
  7. Grisham
    Grisham
  8. Ilson
    Ilson
  9. Korde
    Korde
  10. Ku
    Ku

Groups

  1. Department of Medicine (53)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (35)
  4. Lymphoma (18)
  5. Adult Leukemia (11)
  6. Population Sciences Research Program (11)
  7. Hematologic Malignancies Research (4)
  8. Solid Tumor Oncology Division (4)
  9. GSK Faculty (3)
  10. Survivorship Research (3)
Search Within
  1. "Hematologic Malignancies, Division of"
Formats
  1. Journal Article (43)
  2. Review (4)
  3. Editorial (3)
  4. Miscellaneous (3)
Groups
  1. Department of Medicine (53)
  2. Hematologic Malignancies, Division of (53)
  3. Center for Hematologic Malignancies (35)
  4. Lymphoma (18)
  5. Adult Leukemia (11)
  6. Population Sciences Research Program (11)

More Groups

People
  1. Steven Horwitz (11)
  2. Craig Moskowitz (9)
  3. Dan Douer (4)
  4. Anthony Mato (3)
  5. Andrew Zelenetz (2)
  6. Carl Landgren (2)

More People

Years
  1. 2024 (2)
  2. 2022 (2)
  3. 2021 (3)
  4. 2020 (4)
  5. 2019 (2)
  6. 2018 (2)

More Years

Publications
  1. Clinical Advances in Hematology & Oncology (53)

Results (53)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Redefining the standard of care for low-grade serous ovarian cancer
    Review

    Manning-Geist, B. L.; Cantor, T.; O'Cearbhaill, R. E.; Grisham, R. N.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • The use of glofitamab in relapsed diffuse large B-cell lymphoma
    Review

    Falchi, L.
    Clinical Advances in Hematology & Oncology (2024)

    Fulltext@MSK | Save
  • Cases in the management of polycythemia vera: The importance of strict hematocrit control
    Journal Article

    Rampal, R. K.
    Clinical Advances in Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Highlights in chronic lymphocytic leukemia from the 63rd American Society of Hematology Annual Meeting and Exposition: Commentary
    Editorial

    Mato, A.
    Clinical Advances in Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • IDH inhibitors in acute myeloid leukemia and myelodysplastic syndrome [Interview]
    Miscellaneous

    Stein, E. M.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • How we treat mycosis fungoides and Sézary syndrome
    Journal Article

    Khan, N.; Noor, S. J.; Horwitz, S.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Highlights in relapsed/refractory follicular lymphoma from the 62nd American Society of Hematology Annual Meeting and Exposition: Commentary
    Editorial

    Salles, G.
    Clinical Advances in Hematology & Oncology (2021)

    Fulltext@MSK | Save
  • Highlights in Hodgkin lymphoma from the 61st American Society of Hematology Annual Meeting: Commentary
    Editorial

    Straus, D. J.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • Assessment of minimal residual disease (MRD) in chronic lymphocytic leukemia: A review of the data and future directions
    Review

    Mato, A. R.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save
  • The evolving use of minimal residual disease (MRD) assessment in chronic lymphocytic leukemia: Q&A
    Miscellaneous

    Cheson, B. D.; Mato, A. R.
    Clinical Advances in Hematology & Oncology (2020)

    Fulltext@MSK | Save

    • Millennium Medical Publishing, Inc – authorized name for: